Pharmacy

Pharmacy procurement becomes increasingly difficult to manage as health systems expand.  Many organizations have centralized strategies in place, yet purchasing decisions remain reactive. The result: inconsistency, missed savings and increased compliance risk across the enterprise. This session explores where traditional…

Across health systems, revenue can be lost at multiple points in the medication journey, from prescriptions that are abandoned to therapies that never begin to claims that end in write-offs. Those losses are often addressed separately. Pharmacy leaders focus on…

When pharmacy vacancies remain open, the effects are felt across the department. Workflows slow, overtime rises, clinical capacity is reduced and team burnout becomes harder to contain. This webinar will help pharmacy leaders look beyond hourly rates and better understand…

As pharmacy plays an increasingly central role in both patient care and financial performance, alignment between the CFO and chief pharmacy officer is becoming non-negotiable for many health systems. Stronger collaboration between finance and pharmacy leaders can help organizations better…

Starting specialty therapy can involve navigating as many as nine separate platforms.For health systems, medical centers and hospital pharmacies, that fragmentation slows treatment initiation and complicates coordination across stakeholders. In oncology, even small delays can carry significant clinical and operational…

Pharmacy procurement is no longer just about purchasing medications. Rising drug costs, persistent shortages, limited staffing and growing 340B complexity are forcing pharmacy leaders into broader financial and operational decisions, often without connected data or workflows to support them. In…

Pharmacy operations have shifted from a departmental function to a board-level priority as margin pressure and compliance exposure intensify across health systems. Yet many organizations still operate with fragmented procurement models and legacy oversight approaches that limit control and visibility.…

Specialty drug growth is accelerating, but billing infrastructure has not kept pace. High-cost therapies now represent a growing share of total drug spend and pipeline volume. At the same time, medical benefit claims, prior authorizations, payer policy changes and 340B…

With over 200 active drug shortages in 2025 supply chain disruptions have become a daily operational threat for hospital pharmacies. But UVA Health is showing that health systems don’t have to accept chaos as the norm. By partnering on a…